Zeng-Jun Li
Overview
Explore the profile of Zeng-Jun Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang W, Zhang W, Su L, Liu L, Gao Y, Wang Q, et al.
Ann Hematol
. 2024 May;
103(8):3061-3069.
PMID: 38805037
In this prospective, multicenter, Phase 2 clinical trial (NCT02987244), patients with peripheral T-cell lymphomas (PTCLs) who had responded to first-line chemotherapy with cyclophosphamide, doxorubicin or epirubicin, vincristine or vindesine, etoposide,...
2.
Ma D, Li Z, Wang X, Zhu X, Sun Y
Transl Cancer Res
. 2022 Feb;
8(6):2284-2294.
PMID: 35116981
Background: Patients receiving radiotherapy and chemotherapy have a high risk developing to an acute chemoradiotherapy-induced diarrhea (RID). The clinical efficacy of octreotide in controlling chemoradiotherapy-induced diarrhea remains controversial. We performed...
3.
Mao X, Zhuang J, Zhao D, Li X, Du X, Hao M, et al.
Eur J Haematol
. 2020 May;
105(3):326-334.
PMID: 32421883
Background: In multiple myeloma (MM), impact of specific chromosomal translocations involving IgH (14q21 locus, including t(4;14), t(11;14), and t(14;16)) has been explored extensively. However, over 15% MM patients harboring IgH...
4.
Lu R, Li Z, An G, Yi S, Liu W, Wang T, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2019 Jun;
27(3):839-843.
PMID: 31204941
Objective: To investigate the clinical characteristics and therapeutic responte of patients with B-CLPD mainly manifested as cytopenia, so as to deeply understand this disease. Methods: The clinical data of 13...
5.
Qin X, An G, Li Z, Liu L, Xu Y, Yang L, et al.
Blood Adv
. 2019 Mar;
3(5):751-760.
PMID: 30833275
The treatment of multiple myeloma (MM) with proteasome inhibitor (PI) bortezomib has significantly improved the survival of patients with MM. The 26S proteasome inhibitor targets the unfolded protein response (UPR)...
6.
Ma D, Wang B, Yue J, Li Z, Sun Y
Onco Targets Ther
. 2018 Dec;
11:8987-8993.
PMID: 30588011
Familial adenomatous polyposis (FAP) is a rare autosomal dominant genetic disease related to germline mutations of the gene. The clinical features of this disease most commonly include hundreds of adenomas...
7.
Li H, Yi S, Xiong W, Liu H, Lyu R, Wang T, et al.
Chin Med J (Engl)
. 2017 Jan;
130(2):135-142.
PMID: 28091403
Background: The established clinical staging systems (Rai/Binet) of chronic lymphocytic leukemia (CLL) cannot accurately predict the appropriate treatment of patients in the earlier stages. In the past two decades, several...
8.
Xiong W, Li H, Liu H, Yi S, Li Z, Lu R, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2016 Dec;
24(6):1754-1758.
PMID: 28024489
Objective: To investigate the prevalence rate of hepatitis B virus(HBV)and hepatitis C virus(HCV)between aggressive and indolent B cell non-Hodgkin's lymphoma (B-NHL), and to compare the different infection rate of Hepatifis...
9.
Lyu R, Yi S, Li Z, Liu W, Li H, Xiong W, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2015 Nov;
23(5):1309-13.
PMID: 26524028
Objective: To investigate the clinical characteristics, treatment and prognosis of splenic marginal zone lymploma (SMZL). Methods: A total of 91 cases of SMZL admitted in our hospital from January 2002...
10.
Xu Z, Li Z, Sun Y, Zheng Y, Shi H, Zhen Y, et al.
J Laparoendosc Adv Surg Tech A
. 2015 Apr;
25(4):323-9.
PMID: 25853183
Background: We designed a novel, spherical magnetic compression colorectal anastomosis device and established a swine model to assess the feasibility and safety, as well as advantages, of the device. Methods...